Omid Farokhzad
Also at Seer Inc
About
Omid Farokhzad, M.D., has been a transformative force at SEER, having co-founded the company and contributed significantly to its strategic direction since joining as a board member in March 2017.
During his illustrious career, he has combined his strong academic background with extensive industry experience. He earned an M.A. and M.D. from Boston University and an M.B.A. from the Massachusetts Institute of Technology Sloan School of Management, which laid the foundation for his dual expertise in science and business.
Before dedicating his primary focus to SEER, he had an accomplished tenure at Harvard Medical School, where he directed the Center for Nanomedicine at Brigham and Women’s Hospital. This period emphasized his commitment to advancing healthcare and biomedical innovation.
At SEER, his leadership journey is marked by his role as Chief Executive Officer beginning in February 2018, his appointment as Chair in September 2020, and his period as President from September 2022 to November 2023. His visionary and multifaceted approach has driven significant contributions to the company's growth and evolution in the competitive biotechnology landscape.